LabCorp Announces Proposed Sale of Senior Notes

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 18, 2019-- LabCorp® (NYSE: LH) announced today that it plans to offer, subject to market and other conditions, senior notes that are expected to be issued in two tranches (the Notes). The Notes will be senior unsecured obligations and will rank equally with

LabCorp Announces Departure of John Ratliff, Names New LabCorp Diagnostics Leadership

John Ratliff is departing the company to pursue another opportunity Dr. Brian Caveney has been named executive vice president and president of Diagnostics Mark Schroeder has been named executive vice president and president of Diagnostics laboratory operations and global supply chain These new

LabCorp Announces 2019 Third Quarter Results and Updates 2019 Guidance

Q3 revenue of $2.9 billion , up 3.4% over $2.8 billion last year Q3 diluted EPS of $2.25 , down from $3.10 last year, which included the net gain on the disposition of the Food Solutions business of $1.22 per share Q3 adjusted EPS of $2.90 , up 5.8% over $2.74 last year Q3 free cash flow of $363